These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25159159)

  • 1. Natural product chemokine receptor antagonists: What mother nature has offered us?
    Yuan Y
    Curr Top Med Chem; 2014; 14(13):1619-34. PubMed ID: 25159159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of chemokine receptor function.
    Scholten DJ; Canals M; Maussang D; Roumen L; Smit MJ; Wijtmans M; de Graaf C; Vischer HF; Leurs R
    Br J Pharmacol; 2012 Mar; 165(6):1617-1643. PubMed ID: 21699506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
    Russo RC; Garcia CC; Teixeira MM
    Curr Opin Drug Discov Devel; 2010 Jul; 13(4):414-27. PubMed ID: 20597027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
    Carter PH; Tebben AJ
    Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of chemokines with their receptors--from initial chemokine binding to receptor activating steps.
    Thiele S; Rosenkilde MM
    Curr Med Chem; 2014; 21(31):3594-614. PubMed ID: 25039782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifunctional Role of the Chemokine System in Arthritogenic Processes.
    Bernardini G; Benigni G; Scrivo R; Valesini G; Santoni A
    Curr Rheumatol Rep; 2017 Mar; 19(3):11. PubMed ID: 28265846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Arylalkylpiperidine urea derivatives as CC chemokine receptor-3 (CCR3) antagonists.
    Batt DG; Houghton GC; Roderick J; Santella JB; Wacker DA; Welch PK; Orlovsky YI; Wadman EA; Trzaskos JM; Davies P; Decicco CP; Carter PH
    Bioorg Med Chem Lett; 2005 Feb; 15(3):787-91. PubMed ID: 15664858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug discovery and chemokine receptor antagonists: eppur si muove!
    Terricabras E; Benjamim C; Godessart N
    Autoimmun Rev; 2004 Nov; 3(7-8):550-6. PubMed ID: 15546804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines and atherosclerotic plaque progression: towards therapeutic targeting?
    Kraaijeveld AO; de Jager SC; van Berkel TJ; Biessen EA; Jukema JW
    Curr Pharm Des; 2007; 13(10):1039-52. PubMed ID: 17430167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and structures of novel fungal metabolites as chemokine receptor (CCR2) antagonists.
    Herath KB; Jayasuriya H; Ondeyka JG; Polishook JD; Bills GF; Dombrowski AW; Cabello A; Vicario PP; Zweerink H; Guan Z; Singh SB
    J Antibiot (Tokyo); 2005 Nov; 58(11):686-94. PubMed ID: 16466022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine receptor-directed agents as novel anti-HIV-1 therapies.
    Mills SG; DeMartino JA
    Curr Top Med Chem; 2004; 4(10):1017-33. PubMed ID: 15193136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X; Oppenheim JJ; Howard OM
    Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Benzylindole-2-carboxylic acids: potent functional antagonists of the CCR2b chemokine receptor.
    Kettle JG; Faull AW; Barker AJ; Davies DH; Stone MA
    Bioorg Med Chem Lett; 2004 Jan; 14(2):405-8. PubMed ID: 14698169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pharmacology of Chemokine Receptors.
    de Wit RH; de Munnik SM; Leurs R; Vischer HF; Smit MJ
    Methods Enzymol; 2016; 570():457-515. PubMed ID: 26921959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and structure-activity relationship of N-(ureidoalkyl)-benzyl-piperidines as potent small molecule CC chemokine receptor-3 (CCR3) antagonists.
    De Lucca GV; Kim UT; Johnson C; Vargo BJ; Welch PK; Covington M; Davies P; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
    J Med Chem; 2002 Aug; 45(17):3794-804. PubMed ID: 12166951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines: novel targets for breast cancer metastasis.
    Ali S; Lazennec G
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):401-20. PubMed ID: 17717637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMM-chemokines: a class of unnatural synthetic molecules as chemical probes of chemokine receptor biology and leads for therapeutic development.
    Kumar S; Choi WT; Dong CZ; Madani N; Tian S; Liu D; Wang Y; Pesavento J; Wang J; Fan X; Yuan J; Fritzsche WR; An J; Sodroski JG; Richman DD; Huang Z
    Chem Biol; 2006 Jan; 13(1):69-79. PubMed ID: 16426973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine receptor modeling: an interdisciplinary approach to drug design.
    Fricker SP; Metz M
    Future Med Chem; 2014 Jan; 6(1):91-114. PubMed ID: 24358950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2.
    Dhanak D; Christmann LT; Darcy MG; Keenan RM; Knight SD; Lee J; Ridgers LH; Sarau HM; Shah DH; White JR; Zhang L
    Bioorg Med Chem Lett; 2001 Jun; 11(11):1445-50. PubMed ID: 11378374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks.
    Olivon F; Allard PM; Koval A; Righi D; Genta-Jouve G; Neyts J; Apel C; Pannecouque C; Nothias LF; Cachet X; Marcourt L; Roussi F; Katanaev VL; Touboul D; Wolfender JL; Litaudon M
    ACS Chem Biol; 2017 Oct; 12(10):2644-2651. PubMed ID: 28829118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.